Pranav Dalal

Bio: Pranav Dalal is an academic researcher from Duquesne University. The author has contributed to research in topics: Antifreeze protein & Ice crystals. The author has an hindex of 7, co-authored 10 publications receiving 321 citations. Previous affiliations of Pranav Dalal include Case Western Reserve University & University of South Alabama.

Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes

Abstract: The expression of P2 purinergic receptor subtypes in leukocytes varies with both lineage and developmental stage. Given the recent identification and cloning of at least seven distinct G protein-coupled ATP receptor subtypes (P2Y family), we investigated P2Y receptor subtype expression during myeloid cell differentiation. We observed that KG-1 myeloblasts express P2Y1 but not P2Y2 receptors (previously termed P2U receptors), whereas later myeloid progenitors, including HL-60 promyelocytes and THP-1 monocytes, expressed P2Y2 but not P2Y1 receptors. In KG-1 cells, significant activation of Ca2+ mobilization by P2Y1 receptors was only observed after preincubation with potato apyrase, an exogenous ATPase. This indicated that P2Y1 receptors are desensitized in KG-1 cells by autocrine mechanisms that may involve enhanced release of endogenous nucleotides and/or decreased expression of cell-surface ecto-nucleotidases. We compared the levels of ecto-apyrase activity and expression in KG-1 myeloblasts and HL-60 promyelocytes. Extracellular ATP was rapidly metabolized by HL-60 but not by KG-1 cells. Reverse transcription-polymerase chain reaction analysis indicated that mRNA for CD39 (cluster of differentiation), an identified ecto-apyrase, was present in HL-60 but not KG-1 cells. Ecto-apyrase activity was modestly increased with differentiation of myeloid progenitors with either phorbol 12-myristate 13-acetate (PMA) or dibutyryl adenosine 3',5'-cyclic monophosphate (DBcAMP). Differentiation of HL-60 cells with PMA, but not DBcAMP, strongly induced ecto-5'-nucleotidase activity and CD73 mRNA expression. These observations indicate that signal transduction by extracellular ATP in myeloid leukocytes can be regulated by developmentally programmed changes in the expression of P2Y receptor subtypes and multiple ecto-nucleotidases.

Source of the ice-binding specificity of antifreeze protein type I.

Abstract: Antifreeze proteins (AFPs) are a group of structurally very diverse proteins with the unique capability of binding to the surface of seed ice crystals and inhibiting ice crystal growth. The AFPs bi...

Hydrogen bond analysis of Type 1 antifreeze protein in water and the ice/water interface

Abstract: Antifreeze proteins (AFPs) are a group of structurally very diverse proteins with the unique capability of inhibiting ice crystal growth. Although significant progress has been made in the identification of different families of these proteins, the molecular mechanism of their action is unclear. The previously postulated mechanism of hydrogen bonding between the threonine residues of AFP and the water molecules in the ice surface has been disproved by mutation studies with non-polar residues. Currently, the mechanism of antifreeze activity cannot be fully understood from experimental or computational studies. Computational modeling studies have examined protein–ice interactions, mostly in vacuo. These studies have neglected the effects of the water phase. It has been shown that the vacuum is a very poor approximation for the water properties. Thus, to gain an insight into the molecular mechanism of these proteins we have computationally modeled a more realistic system comprising of AFP Type I from winter flounder (HPLC6), water and ice without any constraints. The results from this study show that the protein forms hydrogen bonds with the water molecules in the ice/water interfacial region. However, a comparison of the results with the protein in water simulations shows that there is no significant gain of hydrogen bonds for protein in the interfacial region compared to in the solvent. These results support the hypothesis that hydrogen bonding is not the primary reason for interaction of HPLC6 with the ice/water interfacial region.

Molecular Dynamics Simulation of Crystal-Induced Membranolysis

Abstract: Calcium pyrophosphate dihydrate (CPPD) crystals occur frequently in noninflammatory osteoarthritic joints; however, they can be phlogistic and membranolytic, causing acute pseudogout attack. So far, the molecular mechanism of crystal-induced membranolysis is still unclear. In this study, using the method of Chemistry at Harvard Macromolecular Mechanics (CHARMM) molecular dynamics, we show that the interactions between the surface of CPPD crystal and the extracellular layer of the hydrated dimyristoyl phosphatidylcholine (DMPC) phospholipid bilayer may lead to decoupling of the external layer from the intracellular side of the membrane. As a result, a local thinning of the layer on the intracellular side of the membrane occurs, which favors water penetration, leading to membranolysis.

Cellular distribution and functions of P2 receptor subtypes in different systems.

Abstract: This review is aimed at providing readers with a comprehensive reference article about the distribution and function of P2 receptors in all the organs, tissues, and cells in the body. Each section provides an account of the early history of purinergic signaling in the organ/cell up to 1994, then summarizes subsequent evidence for the presence of P2X and P2Y receptor subtype mRNA and proteins as well as functional data, all fully referenced. A section is included describing the plasticity of expression of P2 receptors during development and aging as well as in various pathophysiological conditions. Finally, there is some discussion of possible future developments in the purinergic signaling field.

Inverse, protean, and ligand-selective agonism: matters of receptor conformation

Abstract: Concepts regarding the mechanisms by which drugs activate receptors to produce physiological response have progressed beyond considering the receptor as a simple on-off switch. Current evidence suggests that the idea that agonists produce only varying degrees of receptor activation is obsolete and must be reconciled with data to show that agonist efficacy has texture as well as magnitude. Thus, agonists can block system constitutive response (inverse agonists), behave as positive and inverse agonists on the same receptor (protean agonists), and differ in the stimulus pattern they produce in physiological systems (ligand-selective agonists). The molecular mechanism for this seemingly diverse array of activities is the same, namely, the selective microaffinity of ligands for different conformational states of the receptor. This paper reviews evidence for the existence of the various types of agonism and the potential therapeutic utility of different agonist types.-Kenakin, T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation.